disease location, imaging, and risk assessment - 2019 prostate cancer patient conference
Published 5 years ago • 5.2K plays • Length 31:51Download video MP4
Download video MP3
Similar videos
-
30:06
intermediate and "high-risk" prostate cancer - 2019 prostate cancer patient conference
-
14:20
prostate cancer epidemiology, screening and diagnosis - 2021 prostate cancer patient conference
-
34:43
prostate cancer: evaluation and management of low risk disease
-
23:30
psa recurrence, risk assessment - 2021 prostate cancer patient conference
-
27:01
risk assessment of psa recurrent prostate cancer
-
6:09
staging prostate cancer - mri, pirads, & psma | are biopsies still needed? | mark scholz, md | pcri
-
15:48
active surveillance for prostate cancer
-
32:28
prostate cancer and androgen deprivation therapy
-
16:06
introduction and welcome - 2019 prostate cancer patient conference
-
36:19
localized prostate cancer: risk stratification - 2021 prostate cancer patient conference
-
39:34
approaches to treatment decision-making - 2019 prostate cancer patient conference
-
15:57
localized prostate cancer: radiation - 2021 prostate cancer patient conference
-
17:37
localized prostate cancer: surgery - 2021 prostate cancer patient conference
-
12:25
psma pet and functional imaging - 2021 prostate cancer patient conference
-
19:04
functional imaging and recurring prostate cancer
-
11:39
oligometastatic disease - 2021 prostate cancer patient conference
-
14:34
introduction - 2021 prostate cancer patient conference
-
19:27
prostate cancer: the abcs of initial evaluation
-
48:23
recurrent prostate cancer cases - 2021 prostate cancer patient conference
-
16:45
untreated metastatic prostate cancer - 2021 prostate cancer patient conference
-
1:24:30
prostate health: risk detection and optimizing personalized treatment